Telehealth behavioral treatment for medication nonadherence: A pilot and feasibility study

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 4, 2013, Pages 469-473

  Hommel, Kevin A ^a,b   Hente, Elizabeth ^a   Herzer, Michele ^c,d   Ingerski, Lisa M ^e   Denson, Lee A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

adherence; compliance; inflammatory bowel disease; medication; pediatric

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE;

ADOLESCENT; ARTICLE; BEHAVIOR THERAPY; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COST CONTROL; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HUMAN; INTERNAL CONSISTENCY; MALE; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; TELEHEALTH; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; BEHAVIOR THERAPY; CHILD; COST OF ILLNESS; DELIVERY OF HEALTH CARE; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; MESALAMINE; OHIO; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TELEMEDICINE; TREATMENT OUTCOME;

EID: 84875222036     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835c2a1b     Document Type: Article

References (10)

1. Rapoff MA. Adherence to pediatric medical regimens. 2nd ed. New York: Springer; 2010.
2. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother 1993; 27 (Suppl):S1-24.
3. DiMatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns 2004; 55:339-344.
4. Logan D, Zelikovsky N, Labay L, Spergel J. The illness management survey: identifying adolescents' perceptions of barriers to adherence. J Pediatr Psychol 2003; 28:383-392.
5. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:589-593.
6. Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003; 114:39-43.
7. Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2012; 24:64-69.
8. Hommel KA, Herzer M, Ingerski LM, Hente E, Denson LA. Individually-tailored treatment of medication nonadherence. J Pediatr Gastroenterol Nutr 2011; 53:435-439.
9. Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007; 133:423-432.
10. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119:895-902.